End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
780,000 KRW | -1.27% | +0.52% | +2.63% |
08:05am | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
07:19am | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.63% | 40.86B | |
-2.86% | 87.31B | |
-21.76% | 29.36B | |
+58.56% | 24.49B | |
-14.78% | 17.31B | |
-18.49% | 11.62B | |
-15.61% | 11.31B | |
-44.02% | 11.26B | |
+5.17% | 8.31B | |
-9.82% | 7.9B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Biologics : C&T's Q4 Net Profit Declines 24% on Lower Equity Gains, Higher Costs; Shares Drop 4%